Important Safety Information Prescribing Information Instructions for Use
MyELOCTATE Peers™ are people using ELOCTATE, or who are caring for someone using ELOCTATE. They choose to share their experiences to help support others living with Hemophilia A.
If you are interested in this opportunity, we'd like to hear from you. Please call 1-855-491-1866 or complete the form below for more information. This program is sponsored by Sanofi Genzyme.
*Indicates a required field
*First Name *Last Name
Address 1 Address 2
City State
Zip *Phone
*E-mail
*Are you, or a loved one, using ELOCTATE for Hemophilia A?
*Are you willing to share your Hemophilia A experiences with
other patients and/or caregivers?
*I am over 18 years of age
*Are you related to anyone currently employed at Bioverativ or Sanofi Genzyme?
*I have read and agree with the Privacy Policy Statement
Indications and Important Safety Information
Indications
ELOCTATE, Antihemophilic Factor (Recombinant), Fc Fusion Protein, is a recombinant DNA derived, antihemophilic factor indicated in adults and children with Hemophilia A (congenital Factor VIII deficiency) for:
  • On-demand treatment and control of bleeding episodes
  • Perioperative management of bleeding
  • Routine prophylaxis to reduce the frequency of bleeding episodes.
ELOCTATE is not indicated for the treatment of von Willebrand disease
Important Safety Information
Do not use ELOCTATE if you have had an allergic reaction to it in the past.
Tell your healthcare provider if you have or have had any medical problems, take any medicines, including prescription and non-prescription medicines, supplements, or herbal medicines, have any allergies, are breastfeeding, are pregnant or planning to become pregnant, or have been told you have inhibitors (antibodies) to Factor VIII.
Allergic reactions may occur with ELOCTATE. Call your healthcare provider or get emergency treatment right away if you have any of the following symptoms: difficulty breathing, chest tightness, swelling of the face, rash, or hives.
Your body can also make antibodies called, "inhibitors," against ELOCTATE, which may stop ELOCTATE from working properly.
The most frequently occurring side effects of ELOCTATE are headache, rash, joint pain, muscle pain and general discomfort. These are not all the possible side effects of ELOCTATE. Talk to your healthcare provider right away about any side effect that bothers you or that does not go away, and if bleeding is not controlled after using ELOCTATE.
Please see full Prescribing Information.
© 2019 Bioverativ, a Sanofi Company. All Rights Reserved. 07/2019 ELO-US-1381 V3